ATE207887T1 - Neue n-aryl-2-hydroxy-alkylamide - Google Patents
Neue n-aryl-2-hydroxy-alkylamideInfo
- Publication number
- ATE207887T1 ATE207887T1 AT98402503T AT98402503T ATE207887T1 AT E207887 T1 ATE207887 T1 AT E207887T1 AT 98402503 T AT98402503 T AT 98402503T AT 98402503 T AT98402503 T AT 98402503T AT E207887 T1 ATE207887 T1 AT E207887T1
- Authority
- AT
- Austria
- Prior art keywords
- halogen
- alkyl
- optionally substituted
- aryl
- alkylamides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/50—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714241A FR2770842B1 (fr) | 1997-11-13 | 1997-11-13 | Nouveaux composes derives de n-aryl 2-hydroxy alkylamides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE207887T1 true ATE207887T1 (de) | 2001-11-15 |
Family
ID=9513334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98402503T ATE207887T1 (de) | 1997-11-13 | 1998-10-08 | Neue n-aryl-2-hydroxy-alkylamide |
Country Status (8)
Country | Link |
---|---|
US (1) | US6156899A (de) |
EP (1) | EP0916652B1 (de) |
JP (1) | JP3222846B2 (de) |
AT (1) | ATE207887T1 (de) |
CA (1) | CA2251003C (de) |
DE (1) | DE69802249T2 (de) |
ES (1) | ES2167853T3 (de) |
FR (1) | FR2770842B1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59913181D1 (de) * | 1998-10-23 | 2006-04-27 | Aventis Pharma Sa | Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen |
WO2000029425A1 (fr) * | 1998-11-13 | 2000-05-25 | Kyowa Hakko Kogyo Co., Ltd. | Peptides actifs physiologiquement |
DE10025553A1 (de) * | 2000-05-24 | 2001-11-29 | Merck Patent Gmbh | Zusammensetzung, enthaltend mindestens ein Aryloxim und mindestens einen Wirkstoff zur Behandlung von Akne und ihre Verwendung |
FR2811550B1 (fr) * | 2000-07-11 | 2003-02-14 | Oreal | Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux |
JP2008540327A (ja) * | 2004-09-02 | 2008-11-20 | シー.ワイ. シー,チャールズ | 核内受容体転写因子の分解を増強するための方法及び組成物並びにその使用 |
FR2918885B1 (fr) | 2007-07-17 | 2009-08-28 | Oreal | Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires |
JP2010200971A (ja) * | 2009-03-03 | 2010-09-16 | Hoyu Co Ltd | 異常脱毛予測/推定方法、異常脱毛予防/防止方法及び異常脱毛防止剤評価方法 |
CA2788907A1 (en) | 2010-02-04 | 2011-08-11 | Radius Health, Inc. | Selective androgen receptor modulators |
MX342898B (es) | 2010-05-12 | 2016-10-18 | Radius Health Inc * | Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol. |
ES2550319T3 (es) | 2010-09-28 | 2015-11-06 | Radius Health, Inc | Moduladores selectivos del receptor de andrógenos |
FR3015282B1 (fr) | 2013-12-20 | 2016-01-22 | Oreal | Utilisation cosmetique d'une huile essentielle de laserpitium siler l. pour les matieres keratiniques. |
SI3122426T1 (sl) | 2014-03-28 | 2023-04-28 | Duke University | Zdravljenje raka dojk z uporabo selektivnih modulatorjev estrogenskih receptorjev |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
LT3474841T (lt) | 2016-06-22 | 2022-06-10 | Ellipses Pharma Ltd | Ar+ krūties vėžio gydymo būdai |
LT3565542T (lt) | 2017-01-05 | 2024-07-10 | Radius Pharmaceuticals, Inc. | Polimorfinės rad1901-2hcl formos |
CN112423844B (zh) | 2018-07-04 | 2024-08-13 | 雷迪厄斯制药公司 | Rad1901-2hcl的多晶型形式 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
EP0886515B1 (de) * | 1996-03-06 | 2002-01-16 | L'oreal | Verwendung von n-aryl-2-hydroxyalkylamiden zur induzierung und/oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls |
-
1997
- 1997-11-13 FR FR9714241A patent/FR2770842B1/fr not_active Expired - Fee Related
-
1998
- 1998-10-08 ES ES98402503T patent/ES2167853T3/es not_active Expired - Lifetime
- 1998-10-08 EP EP98402503A patent/EP0916652B1/de not_active Expired - Lifetime
- 1998-10-08 DE DE69802249T patent/DE69802249T2/de not_active Expired - Fee Related
- 1998-10-08 AT AT98402503T patent/ATE207887T1/de active
- 1998-11-02 JP JP31236698A patent/JP3222846B2/ja not_active Expired - Fee Related
- 1998-11-12 CA CA002251003A patent/CA2251003C/fr not_active Expired - Fee Related
- 1998-11-13 US US09/190,300 patent/US6156899A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69802249T2 (de) | 2002-05-02 |
CA2251003C (fr) | 2003-10-07 |
FR2770842A1 (fr) | 1999-05-14 |
CA2251003A1 (fr) | 1999-05-13 |
DE69802249D1 (de) | 2001-12-06 |
EP0916652A1 (de) | 1999-05-19 |
JP3222846B2 (ja) | 2001-10-29 |
ES2167853T3 (es) | 2002-05-16 |
FR2770842B1 (fr) | 1999-12-17 |
JPH11228525A (ja) | 1999-08-24 |
US6156899A (en) | 2000-12-05 |
EP0916652B1 (de) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE207887T1 (de) | Neue n-aryl-2-hydroxy-alkylamide | |
ATE116295T1 (de) | Perhydroisoindol derivate und ihre herstellung. | |
FI965020A0 (fi) | Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita | |
FI894061A (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
FI945581A (fi) | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina | |
ATE104965T1 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
ATE130851T1 (de) | Substituierte n-phenylpiperidine und arzneimittel daraus. | |
DK0499544T3 (da) | Anvendelse af tetrahydrothienopyridinderivater som inhibitorer af angiogenese | |
FI941068A0 (fi) | Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
DE69705376D1 (de) | Aminomethylheterozyclischederivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69823411D1 (de) | 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
DE3161510D1 (en) | Cinnamoyl-cinnamic acid derivative, its preparation and its use as a therapeutic agent | |
DK0906912T3 (da) | Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse | |
DE69319902D1 (de) | Neue perhydroisoindolderivate und ihre herstellung | |
DE69515402D1 (de) | Oxazolochinolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel | |
DE59712053D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
PT916671E (pt) | Novos inibidores de metaloproteases processo para a sua preparacao e as suas composicoes farmaceuticas que os contem | |
YU16196A (sh) | Upotreba novih benzohinolin-3-ona i njihovih farmaceutski prihvatljivih soli za proizvodnju leka | |
NO955103D0 (no) | Anvendelse av 1,2-broholdige 1,4-dihydropyridiner som legemiddel | |
RS50790B (sr) | Korišćenje derivata piridoindolona za spravljanje lekova | |
ATE199897T1 (de) | Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE59712054D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
MY111111A (en) | Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl -1-heterocyclyl) methylamine drrivatives | |
DK0532725T3 (da) | Isoxazolderivater som lysfilterpræparater | |
ES539955A0 (es) | Un procedimiento de preparar derivados de oxisalicilamida |